claim
Senomorphic agents that target matrix metalloproteinases (MMPs) reduce osteoarthritis (OA) symptoms, increase type II collagen, and inhibit chondrocyte degeneration in wild-type (WT) mice.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (2)
- osteoarthritis concept
- matrix metalloproteinases concept